← Back to Search

Informational Interventions for COVID-19 Booster Uptake

N/A
Recruiting
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week after getting the text message
Awards & highlights

Study Summary

This trial looks into how text reminders can increase people's desire to get the COVID-19 booster shot. The study will assess how info & consistency can improve uptake.

Who is the study for?
This trial is for adults aged 18 or older who have completed their initial COVID-19 vaccine series and haven't had a booster in at least two months. They must have an SMS-capable phone number registered with UCLA Health but can't join if they've already scheduled or received the bivalent booster.Check my eligibility
What is being tested?
The study tests whether text reminders that provide information about COVID-19, emphasize consistency with past actions, and explain the uniqueness and eligibility for the bivalent booster can increase people's intentions to get this updated shot.See study design
What are the potential side effects?
Since this trial focuses on communication strategies rather than medical interventions, there are no direct side effects from participating. However, general side effects of COVID-19 boosters may include sore arm, fatigue, fever.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week after getting the text message
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week after getting the text message for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Secondary Immunization
Secondary Immunization
Secondary outcome measures
Link click rate in 1 week

Trial Design

7Treatment groups
Experimental Treatment
Active Control
Group I: Uniqueness information reminderExperimental Treatment2 Interventions
Group II: Simple reminderExperimental Treatment1 Intervention
Group III: Severity information reminderExperimental Treatment2 Interventions
Group IV: Eligibility information reminderExperimental Treatment2 Interventions
Group V: Consistency reminderExperimental Treatment2 Interventions
Group VI: Consistency and uniqueness information reminderExperimental Treatment3 Interventions
Group VII: HoldoutActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,538 Previous Clinical Trials
10,107,031 Total Patients Enrolled
21 Trials studying COVID-19
713,075 Patients Enrolled for COVID-19

Media Library

Simple reminder Clinical Trial Eligibility Overview. Trial Name: NCT05586178 — N/A
COVID-19 Research Study Groups: Simple reminder, Consistency reminder, Severity information reminder, Holdout, Eligibility information reminder, Consistency and uniqueness information reminder, Uniqueness information reminder
COVID-19 Clinical Trial 2023: Simple reminder Highlights & Side Effects. Trial Name: NCT05586178 — N/A
Simple reminder 2023 Treatment Timeline for Medical Study. Trial Name: NCT05586178 — N/A
~61935 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top